Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01101451
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
GOG Foundation 340
Early research (Phase 1)Study completedNCT01975831
What this trial is testing

Evaluate MEDI4736 in Combination With Tremelimumab

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
Ludwig Institute for Cancer Research 104
Not applicableStudy completedNCT01569672
What this trial is testing

Ohio Patient Navigator Research Program

Who this might be right for
Breast CancerCervical CancerColon Cancer+4 more
Ohio State University Comprehensive Cancer Center 941
Testing effectiveness (Phase 2)Study completedNCT04542356
What this trial is testing

Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Early research (Phase 1)Ended earlyNCT02317302
What this trial is testing

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Who this might be right for
Cervical CancerUterine Cervical CancerUterine Cervical Neoplasms
Washington University School of Medicine 48
Not applicableStudy completedNCT02276521
What this trial is testing

Evaluation of Long Term Immunity Following HPV Vaccination

Who this might be right for
Cervical CancerAnogenital Warts
Murdoch Childrens Research Institute 200
Not applicableUnknownNCT02292914
What this trial is testing

Prospective Analysis of Robot-Assisted Surgery

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+7 more
Instituto do Cancer do Estado de São Paulo 1,120
Testing effectiveness (Phase 2)Ended earlyNCT03386721
What this trial is testing

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers
Hoffmann-La Roche 256
Not applicableActive Not RecruitingNCT00579163
What this trial is testing

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsColonic Neoplasms+4 more
Memorial Sloan Kettering Cancer Center 992
Not applicableStudy completedNCT05907187
What this trial is testing

Research in Ethno-Medicine and Education (REMED)

Who this might be right for
Cervical CancerHuman Papilloma VirusHPV+1 more
University of Miami 100
Testing effectiveness (Phase 2)Study completedNCT03476798
What this trial is testing

Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium

Who this might be right for
Cervical CancerEndometrial Cancer
University of Oklahoma 49
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Early research (Phase 1)Study completedNCT00315861
What this trial is testing

Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+1 more
SCRI Development Innovations, LLC 15
Large-scale testing (Phase 3)Study completedNCT00122772
What this trial is testing

CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

Who this might be right for
Cervix Cancer
International Atomic Energy Agency 601
Very early researchUnknownNCT05812677
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial CancerAdvanced Cancer
Shanghai Yunying Medical Technology 20
Large-scale testing (Phase 3)WithdrawnNCT00953641
What this trial is testing

Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy

Who this might be right for
MenorrhagiaEndometrial BiopsyCervical Ripening
University of Saskatchewan
Very early researchUnknownNCT04674488
What this trial is testing

TILs for Treatment of Metastatic or Recurrent Cervical Cancer

Who this might be right for
TILs, Metastatic or Recurrent Cervical Cancer
Shanghai OriginCell Therapeutics Co., Ltd. 15
Not applicableUnknownNCT02605941
What this trial is testing

DNA Methylation Biomarkers for Cervical Cancer Screening

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical Cancer
iStat Biomedical CO., Ltd. 5,000
Not applicableUnknownNCT01881659
What this trial is testing

Cervical Cancer Screening With Human Papillomavirus Testing

Who this might be right for
CIN3CIN2Cervical Cancer
International Agency for Research on Cancer 50,000
Next Page